Doctor profile · Federal record
Dr. HARI KALLA, MD
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Medical Oncology Physician · ABILENE, TX
- NPI 1558305482
- Accepts Medicare
- MIPS 86.7 / 100 · 2023
- 33 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1957 ANTILLEY RD
ABILENE, TX 796065208
(325) 692-0188
fax (325) 698-4250 - Mailing address
-
PO BOX 911230
DALLAS, TX 753911230
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- February 21, 2008
- Year of graduation
- 1993 — 33 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Texas #L7769
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1558305482. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
108,466
Distinct HCPCS
10
Medicare allowed
$1,387,475
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 34,680 | 56 | $0 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 17,300 | 13 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 8,480 | 16 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 8,200 | 13 | $54 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 7,326 | 62 | $0 | |
J1756 |
Injection, iron sucrose, 1 mg | 4,700 | 13 | $0 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 4,613 | 19 | $3 | |
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 3,310 | 11 | $42 | |
Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 3,000 | 16 | $29 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,247 | 75 | $0 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 1,523. This provider delivers 71× the peer median.Open Payments
Industry payments received
All-time total
$491
Transactions
7
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Tempus AI, Inc | 3 | $162.90 | |
| Amgen Inc. | 1 | $113.63 | |
| Daiichi Sankyo Inc. | 1 | $104.75 | |
| Genmab U.S., Inc. | 1 | $95.26 | |
| BeiGene USA, Inc. | 1 | $14.61 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
739
Patients
195
Total drug cost
$200,250
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 106 | 23 | $1,775 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 99 | 39 | $5,773 |
| Ondansetron Hcl | Generic | 75 | 40 | $739 |
| Prednisone | Generic | 64 | 22 | $581 |
| Potassium Chloride | Generic | 56 | 17 | $980 |
| Xarelto (Rivaroxaban) | Brand | 51 | 0 | $35,552 |
| Anastrozole | Generic | 44 | 0 | $775 |
| Alprazolam | Generic | 37 | 0 | $466 |
| Eliquis (Apixaban) | Brand | 37 | 0 | $21,706 |
| Dexamethasone | Generic | 32 | 22 | $469 |